<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03957824</url>
  </required_header>
  <id_info>
    <org_study_id>2014_248#C20141535</org_study_id>
    <nct_id>NCT03957824</nct_id>
  </id_info>
  <brief_title>PREVENTION-ACHD Risk Score</brief_title>
  <acronym>PREVENTIONACHD</acronym>
  <official_title>PRospEctiVE Study on implaNTable cardIOverter Defibrillator Therapy and SuddeN Cardiac Death in Adults With Congenital Heart Defects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sudden cardiac death (SCD) is one of the major causes of mortality in adults with congenital
      heart disease (ACHD). Risk stratification for sudden cardiac death in this patient group is
      challenging and at the current moment there are no clear guidelines on implantable
      cardioverter-defibrillator (ICD) implantation for primary prevention of SCD in this young
      patient population. The reason for this is the fact that this is a heterogenous group of
      patients and SCD is a relatively rare event. Because of this there have been no prospective
      studies on SCD in ACHD. However, multiple retrospective studies on ICD implantation in ACHD
      have shown that this treatment does appear to be effective. Researchers from the Academic
      Medical Center have identified several risk factors for sudden cardiac death. A risk score
      was created using this data, which has been validated in an internal and external cohort in a
      retrospective setting. The design of this study, including the conception of the risk score,
      its calculation method and validation will be published in an international scientific
      peer-reviewed journal.

      The hypothesis of this study is that the risk score accurately predicts the risk of sudden
      cardiac death.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Sudden cardiac death and ventricular fibrillation or sustained ventricular tachycardia</measure>
    <time_frame>2 years</time_frame>
    <description>The rate of sudden cardiac death and ventricular fibrillation or sustained ventricular tachycardia in adult congenital heart disease patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sudden cardiac death</measure>
    <time_frame>2 years</time_frame>
    <description>The rate of sudden cardiac death in adult congenital heart disease patients</description>
  </secondary_outcome>
  <enrollment type="Actual">783</enrollment>
  <condition>Death, Sudden, Cardiac</condition>
  <condition>Ventricular Fibrillation</condition>
  <condition>Ventricular Tachycardia</condition>
  <condition>Congenital Heart Disease</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PREVENTION-ACHD risk score</intervention_name>
    <description>The predicted risk of sudden cardiac death according to a risk score will be tested by the actual rate of sudden cardiac death</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with congenital heart disease with a diagnosis of one of the congenital
        heart defects displayed in the risk score model.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult (â‰¥18 years old) patient with a diagnosis of a congenital heart defect.

        Exclusion Criteria:

          -  Patients of whom follow up is not possible, e.g. no permanent home address, living
             outside of or expecting to move out of the area wherein travelling to the
             investigating hospital outpatient clinic is possible.

               -  Patients with documented sustained ventricular tachycardia or ventricular
                  fibrillation.

               -  Patients for whom the risk is not calculable because of a congenital heart
                  disease diagnose not represented in the risk score.

               -  Patients for whom the risk score is not calculable because of missing data

               -  Patients with recent (&lt;3 months ago) myocardial infarction.

               -  Patients in whom the high SCD-risk status depends on an impaired ejection
                  fraction that is expected to improve, e.g. due to tachycardiomyopathy.

               -  Patients with a guideline defined contraindication for ICD implantation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joris R de Groot, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academic Medical Center - University of Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 19, 2019</study_first_submitted>
  <study_first_submitted_qc>May 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2019</study_first_posted>
  <last_update_submitted>May 19, 2019</last_update_submitted>
  <last_update_submitted_qc>May 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Joris R. de Groot</investigator_full_name>
    <investigator_title>Professor of Cardiac Electrophysiology and Atrial Fibrillation</investigator_title>
  </responsible_party>
  <keyword>Risk score</keyword>
  <keyword>Risk prediction</keyword>
  <keyword>Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

